Investigations into the VEGF-C/Flt-4 axis have revealed its capacity to take part in tumor progression by promoting the movement and invasiveness of epithelial tumor cells, as well as LEC proliferation (e.g., lymphangiogenesis) and possible vascular endothelial cell proliferation and migration (e.g., angiogenesis). This evidence concerns the gene FLT4 and neoplasm.